Dear Valued Customer,
In accordance with Reference Listed Drug (RLD) guidelines, this letter is to inform you that Camber Pharmaceuticals/Invagen Pharmaceuticals has received FDA approval for an alternative quantitative formula for Citalopram Tablets, 10mg and 20mg.
The following change in tablet size will occur.
|GENERIC NAME||STRENGTH||OLD TABLET SIZE||NEW TABLET SIZE|
Camber Pharmaceuticals appreciates your continued support and regrets any inconvenience this change may cause you.
Should you have any questions or concerns regarding this change, please contact your Camber Pharmaceuticals National Account Director.
Camber Pharmaceuticals, Inc.